The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

AC1L1GVU     10-(4-aminobutyl)-19-[(2- amino-3-phenyl...

Synonyms:
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Octreotide

 

Associations of Octreotide with other chemical compounds

 

Gene context of Octreotide

References

  1. A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study. Spahr, L., Giostra, E., Frossard, J.L., Morard, I., Mentha, G., Hadengue, A. Am. J. Gastroenterol. (2007) [Pubmed]
  2. Long-term efficacy of octreotide in the prevention of recurrent bleeding from gastrointestinal angiodysplasia. Junquera, F., Saperas, E., Videla, S., Feu, F., Vilaseca, J., Armengol, J.R., Bordas, J.M., Piqué, J.M., Malagelada, J.R. Am. J. Gastroenterol. (2007) [Pubmed]
  3. Selective loss of somatostatin receptor 2 in octreotide-resistant growth hormone-secreting adenomas. Plöckinger, U., Albrecht, S., Mawrin, C., Saeger, W., Buchfelder, M., Petersenn, S., Schulz, S. J. Clin. Endocrinol. Metab. (2008) [Pubmed]
  4. Low levels of raf kinase inhibitory protein in growth hormone-secreting pituitary adenomas correlate with poor response to octreotide treatment. Fougner, S.L., Bollerslev, J., Latif, F., Hald, J.K., Lund, T., Ramm-Pettersen, J., Berg, J.P. J. Clin. Endocrinol. Metab. (2008) [Pubmed]
  5. The somatostatin analogue octreotide inhibits angiogenesis in the earliest, but not in advanced, stages of portal hypertension in rats. Mejias, M., Garcia-Pras, E., Tiani, C., Bosch, J., Fernandez, M. J. Cell. Mol. Med. (2008) [Pubmed]
  6. Octreotide enhances portal pressure reduction induced by propranolol in cirrhosis: a randomized, controlled trial. Vorobioff, J.D., Ferretti, S.E., Zangroniz, P., Gamen, M., Picabea, E., Bessone, F.O., Reggiardo, V., Diez, A.R., Tanno, M., Cuesta, C., Tanno, H.E. Am. J. Gastroenterol. (2007) [Pubmed]
  7. Differential effects of octreotide and pasireotide on somatostatin receptor internalization and trafficking in vitro. Lesche, S., Lehmann, D., Nagel, F., Schmid, H.A., Schulz, S. J. Clin. Endocrinol. Metab. (2009) [Pubmed]
 
WikiGenes - Universities